本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

26.90
+0.10500.39%
成交量:58.28万
成交额:1,562.74万
市值:24.81亿
市盈率:-93.92
高:27.59
开:26.84
低:26.50
收:26.79
52周最高:42.13
52周最低:12.91
股本:9,224.16万
流通股本:9,122.00万
量比:0.81
换手率:0.64%
股息:- -
股息率:- -
每股收益(TTM):-0.2864
每股收益(LYR):-0.2864
净资产收益率:-57.80%
总资产收益率:-6.55%
市净率:21.60
市盈率(LYR):-93.92

数据加载中...

2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/19

重要事件披露

Form 8-K - Current report
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report